Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Related Citations for PubMed (Select 24817950)

1.

Expression of Hsp90α and cyclin B1 were related to prognosis of esophageal squamous cell carcinoma and keratin pearl formation.

Huang T, Chen S, Han H, Li H, Huang Z, Zhang J, Yin Q, Wang X, Ma X, Dai P, Duan D, Zou F, Chen X.

Int J Clin Exp Pathol. 2014 Mar 15;7(4):1544-52. eCollection 2014.

2.

Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.

Takeno S, Noguchi T, Kikuchi R, Uchida Y, Yokoyama S, Müller W.

Cancer. 2002 Jun 1;94(11):2874-81.

3.

USP9X expression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.

Peng J, Hu Q, Liu W, He X, Cui L, Chen X, Yang M, Liu H, Wei W, Liu S, Wang H.

Diagn Pathol. 2013 Oct 23;8:177. doi: 10.1186/1746-1596-8-177.

4.

The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.

Wang WS, Zhong HJ, Xiao DW, Huang X, Liao LD, Xie ZF, Xu XE, Shen ZY, Xu LY, Li EM.

Dis Esophagus. 2010 Aug;23(6):512-21. doi: 10.1111/j.1442-2050.2009.01035.x. Epub 2010 Jan 20.

PMID:
20095995
5.

Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma.

Lv J, Cao XF, Ji L, Zhu B, Wang DD, Tao L, Li SQ.

Med Oncol. 2012 Mar;29(1):151-60. doi: 10.1007/s12032-010-9816-5. Epub 2011 Jan 23.

PMID:
21259057
6.

Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus.

Nozoe T, Korenaga D, Kabashima A, Ohga T, Saeki H, Sugimachi K.

Clin Cancer Res. 2002 Mar;8(3):817-22.

7.

Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage.

Hui MK, Chan KW, Luk JM, Lee NP, Chung Y, Cheung LC, Srivastava G, Tsao SW, Tang JC, Law S.

World J Surg. 2012 Jan;36(1):90-7. doi: 10.1007/s00268-011-1302-5.

8.

Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma.

Zhang H, Chen W, Duan CJ, Zhang CF.

World J Surg Oncol. 2013 Jun 18;11:141. doi: 10.1186/1477-7819-11-141.

9.

Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma.

Murakami H, Furihata M, Ohtsuki Y, Ogoshi S.

Virchows Arch. 1999 Feb;434(2):153-8.

PMID:
10071250
10.

Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis.

Zheng J, Xu C, Chu D, Zhang X, Li J, Ji G, Hong L, Feng Q, Li X, Wu G, Du J, Zhao Q.

Immunol Lett. 2014 Sep;161(1):13-9. doi: 10.1016/j.imlet.2014.04.007. Epub 2014 Apr 21.

PMID:
24768599
11.

Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma.

Liu H, Qin YR, Bi J, Guo A, Fu L, Guan XY.

Dis Esophagus. 2012 Sep-Oct;25(7):656-63. doi: 10.1111/j.1442-2050.2011.01284.x. Epub 2011 Nov 28.

PMID:
22121946
12.

Significance of CD133 expression in esophageal squamous cell carcinoma.

Okamoto H, Fujishima F, Nakamura Y, Zuguchi M, Ozawa Y, Takahashi Y, Miyata G, Kamei T, Nakano T, Taniyama Y, Teshima J, Watanabe M, Sato A, Ohuchi N, Sasano H.

World J Surg Oncol. 2013 Mar 1;11:51. doi: 10.1186/1477-7819-11-51.

13.

Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.

Ren HZ, Pan GQ, Wang JS, Wen JF, Wang KS, Luo GQ, Shan XZ.

Dig Dis Sci. 2010 Sep;55(9):2552-60. doi: 10.1007/s10620-009-1065-0. Epub 2010 Jan 27.

PMID:
20108042
14.

Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.

Cao X, Li Y, Luo RZ, He LR, Yang J, Zeng MS, Wen ZS.

Ann Thorac Surg. 2012 May;93(5):1674-80. doi: 10.1016/j.athoracsur.2011.12.056. Epub 2012 Mar 17.

PMID:
22429674
15.

Expression and prognostic relevance of p21WAF1 in stage III esophageal squamous cell carcinoma.

Liu J, Hu Y, Hu W, Xie X, Ela Bella A, Fu J, Rao D.

Dis Esophagus. 2012 Jan;25(1):67-71. doi: 10.1111/j.1442-2050.2011.01217.x. Epub 2011 Jun 20.

PMID:
21689205
16.

Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.

Hang D, Dong HC, Ning T, Dong B, Hou DL, Xu WG.

Dis Esophagus. 2012 Sep-Oct;25(7):638-44. doi: 10.1111/j.1442-2050.2011.01298.x. Epub 2012 Jan 11.

PMID:
22236447
17.

The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.

Kim SH, Kim JH, Yu EJ, Lee KW, Park CK.

Histol Histopathol. 2012 Jan;27(1):49-58.

PMID:
22127596
18.

XB130 as an independent prognostic factor in human esophageal squamous cell carcinoma.

Shiozaki A, Kosuga T, Ichikawa D, Komatsu S, Fujiwara H, Okamoto K, Iitaka D, Nakashima S, Shimizu H, Ishimoto T, Kitagawa M, Nakou Y, Kishimoto M, Liu M, Otsuji E.

Ann Surg Oncol. 2013 Sep;20(9):3140-50. doi: 10.1245/s10434-012-2474-4. Epub 2012 Jul 18.

PMID:
22805860
19.

Clinicopathological significance of cyclooxygenase-2 and cell cycle-regulatory proteins expression in patients with esophageal squamous cell carcinoma.

Huang JX, Chen WC, Lin M, Zhang YL, Li FY, Song ZX, Xiao W, Chen P, Qian RY, Salminen E, Yu H.

Dis Esophagus. 2012 Feb;25(2):121-9. doi: 10.1111/j.1442-2050.2011.01219.x. Epub 2011 Jul 15.

PMID:
21762277
20.

Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.

Hsu PK, Kao HL, Chen HY, Yen CC, Wu YC, Hsu WH, Chou TY.

J Thorac Cardiovasc Surg. 2014 May;147(5):1612-1618.e4. doi: 10.1016/j.jtcvs.2013.09.066. Epub 2013 Nov 19.

PMID:
24263008
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk